BioCentury | Apr 15, 2013
Company News

PharmaPrint management update

...Calif. Business: Infectious diseases/AIDS Hired: Michael Tempesta, Ph.D., as SVP of research; formerly CSO at Shaman Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Clinical News

Shaman regulatory update

...covering the use of cryptolepine analogs and triterpenoid compounds with hypoglycemic activity to treat diabetes. Shaman Pharmaceuticals Inc....
BioCentury | Jan 11, 2010
Politics, Policy & Law

Shaken, Not Stirred

Like Ted Kennedy, whom he replaced as chair of the Senate Health, Education, Labor and Pensions Committee, Sen. Tom Harkin of Iowa has strong ideas about science and medicine. Unfortunately, the Democrat who now heads...
BioCentury | Aug 7, 2006
Product Development

That old black magic is back

...14.3 million shares at 83p (see Ebb & Flow, A12). Crofelemer originally was developed by Shaman Pharmaceuticals Inc....
...application. However, the agency also wanted out-patient data, which probably meant running another trial. But Shaman...
...for additional data and caused a death spiral," said Lisa Conte, who was CEO of Shaman...
BioCentury | Oct 22, 2001
Company News

Vivus management update

...Zoltowski as VP of regulatory affairs, formerly senior director and head of regulatory affairs at Shaman Pharmaceuticals Inc. WIR...
BioCentury | Oct 2, 2000
Clinical News

Shaman preclinical data

...will be presented in October at the International Society of Ethnobiology meeting in Athens, Ga. Shaman Pharmaceuticals Inc....
BioCentury | Aug 21, 2000
Company News

Shaman board of directors update

Shaman Pharmaceuticals Inc. (SHPH), South San Francisco, Calif. Business: Nutraceuticals Appointed: Nezam Tooloee, a consultant; and Robert Scannell, president of Tradewinds Financial Corp. WIR Staff...
BioCentury | Jul 24, 2000
Company News

Shaman, Royal Numico N.V. sales and marketing update

...an anti-diarrheal dietary supplement. SHPH retains rights to market the product under its own brand. Shaman Pharmaceuticals Inc....
BioCentury | Jul 10, 2000
Clinical News

SB-Normal Stool Formula: Marketed as a dietary supplement

...SHPH’s Shaman.com division reported interim 10-month data from 11 HIV patients with chronic diarrhea that showed...
...of treatment. The interim data will be presented at the International AIDS Conference in Durban. Shaman Pharmaceuticals Inc....
BioCentury | Jan 31, 2000
Company News

Metabolex, Shaman deal

...in animals. SHMN retained rights to its lead diabetes compound Masaprocol. Metabolex Inc., Hayward, Calif. Shaman Pharmaceuticals Inc....
Items per page:
1 - 10 of 86
BioCentury | Apr 15, 2013
Company News

PharmaPrint management update

...Calif. Business: Infectious diseases/AIDS Hired: Michael Tempesta, Ph.D., as SVP of research; formerly CSO at Shaman Pharmaceuticals Inc....
BioCentury | Apr 15, 2013
Clinical News

Shaman regulatory update

...covering the use of cryptolepine analogs and triterpenoid compounds with hypoglycemic activity to treat diabetes. Shaman Pharmaceuticals Inc....
BioCentury | Jan 11, 2010
Politics, Policy & Law

Shaken, Not Stirred

Like Ted Kennedy, whom he replaced as chair of the Senate Health, Education, Labor and Pensions Committee, Sen. Tom Harkin of Iowa has strong ideas about science and medicine. Unfortunately, the Democrat who now heads...
BioCentury | Aug 7, 2006
Product Development

That old black magic is back

...14.3 million shares at 83p (see Ebb & Flow, A12). Crofelemer originally was developed by Shaman Pharmaceuticals Inc....
...application. However, the agency also wanted out-patient data, which probably meant running another trial. But Shaman...
...for additional data and caused a death spiral," said Lisa Conte, who was CEO of Shaman...
BioCentury | Oct 22, 2001
Company News

Vivus management update

...Zoltowski as VP of regulatory affairs, formerly senior director and head of regulatory affairs at Shaman Pharmaceuticals Inc. WIR...
BioCentury | Oct 2, 2000
Clinical News

Shaman preclinical data

...will be presented in October at the International Society of Ethnobiology meeting in Athens, Ga. Shaman Pharmaceuticals Inc....
BioCentury | Aug 21, 2000
Company News

Shaman board of directors update

Shaman Pharmaceuticals Inc. (SHPH), South San Francisco, Calif. Business: Nutraceuticals Appointed: Nezam Tooloee, a consultant; and Robert Scannell, president of Tradewinds Financial Corp. WIR Staff...
BioCentury | Jul 24, 2000
Company News

Shaman, Royal Numico N.V. sales and marketing update

...an anti-diarrheal dietary supplement. SHPH retains rights to market the product under its own brand. Shaman Pharmaceuticals Inc....
BioCentury | Jul 10, 2000
Clinical News

SB-Normal Stool Formula: Marketed as a dietary supplement

...SHPH’s Shaman.com division reported interim 10-month data from 11 HIV patients with chronic diarrhea that showed...
...of treatment. The interim data will be presented at the International AIDS Conference in Durban. Shaman Pharmaceuticals Inc....
BioCentury | Jan 31, 2000
Company News

Metabolex, Shaman deal

...in animals. SHMN retained rights to its lead diabetes compound Masaprocol. Metabolex Inc., Hayward, Calif. Shaman Pharmaceuticals Inc....
Items per page:
1 - 10 of 86